Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities

Oncology is a rapidly evolving field with a shift toward personalized cancer treatment. The use of therapies targeted to the molecular features of individual tumors and the tumor microenvironment has become much more common. In this review, anti-angiogenic and other molecular targeted therapies are...

Descripción completa

Detalles Bibliográficos
Autores principales: Krajewski, Katherine M., Braschi-Amirfarzan, Marta, DiPiro, Pamela J., Jagannathan, Jyothi P., Shinagare, Atul B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2017
Materias:
Cancer Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240491/
https://www.ncbi.nlm.nih.gov/pubmed/28096716
http://dx.doi.org/10.3348/kjr.2017.18.1.28
_version_ 1782496081162010624
author Krajewski, Katherine M.
Braschi-Amirfarzan, Marta
DiPiro, Pamela J.
Jagannathan, Jyothi P.
Shinagare, Atul B.
author_facet Krajewski, Katherine M.
Braschi-Amirfarzan, Marta
DiPiro, Pamela J.
Jagannathan, Jyothi P.
Shinagare, Atul B.
author_sort Krajewski, Katherine M.
collection PubMed
description Oncology is a rapidly evolving field with a shift toward personalized cancer treatment. The use of therapies targeted to the molecular features of individual tumors and the tumor microenvironment has become much more common. In this review, anti-angiogenic and other molecular targeted therapies are discussed, with a focus on typical and atypical response patterns and imaging manifestations of drug toxicities.
format Online
Article
Text
id pubmed-5240491
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Society of Radiology
record_format MEDLINE/PubMed
spelling pubmed-52404912017-01-17 Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities Krajewski, Katherine M. Braschi-Amirfarzan, Marta DiPiro, Pamela J. Jagannathan, Jyothi P. Shinagare, Atul B. Korean J Radiol Cancer Imaging Oncology is a rapidly evolving field with a shift toward personalized cancer treatment. The use of therapies targeted to the molecular features of individual tumors and the tumor microenvironment has become much more common. In this review, anti-angiogenic and other molecular targeted therapies are discussed, with a focus on typical and atypical response patterns and imaging manifestations of drug toxicities. The Korean Society of Radiology 2017 2017-01-05 /pmc/articles/PMC5240491/ /pubmed/28096716 http://dx.doi.org/10.3348/kjr.2017.18.1.28 Text en Copyright © 2017 The Korean Society of Radiology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Imaging
Krajewski, Katherine M.
Braschi-Amirfarzan, Marta
DiPiro, Pamela J.
Jagannathan, Jyothi P.
Shinagare, Atul B.
Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities
title Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities
title_full Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities
title_fullStr Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities
title_full_unstemmed Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities
title_short Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities
title_sort molecular targeted therapy in modern oncology: imaging assessment of treatment response and toxicities
topic Cancer Imaging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240491/
https://www.ncbi.nlm.nih.gov/pubmed/28096716
http://dx.doi.org/10.3348/kjr.2017.18.1.28
work_keys_str_mv AT krajewskikatherinem moleculartargetedtherapyinmodernoncologyimagingassessmentoftreatmentresponseandtoxicities
AT braschiamirfarzanmarta moleculartargetedtherapyinmodernoncologyimagingassessmentoftreatmentresponseandtoxicities
AT dipiropamelaj moleculartargetedtherapyinmodernoncologyimagingassessmentoftreatmentresponseandtoxicities
AT jagannathanjyothip moleculartargetedtherapyinmodernoncologyimagingassessmentoftreatmentresponseandtoxicities
AT shinagareatulb moleculartargetedtherapyinmodernoncologyimagingassessmentoftreatmentresponseandtoxicities

Ejemplares similares